LAX-101
A purified form of eicopentaenoic acid (EPA) that has shown some efficacy in slowing the progression of HD in a phase III clinical trial.
A purified form of eicopentaenoic acid (EPA) that has shown some efficacy in slowing the progression of HD in a phase III clinical trial.